Nigericin Na+ salt, K+ ionophore
Be the first to review this product! Submit a review
|
(4 Publications)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Nigericin Na+ salt, K+ ionophore (AB120494)
ab56889 staining mitofusin 2 in MEF1 cells treated with nigericin Na+ salt (ab120494), by ICC/IF. Decrease in mitofusin 2 expression correlates with increased concentration of nigericin Na+ salt, as described in literature.
The cells were incubated at 37°C for 3h in media containing different concentrations of ab120494 (nigericin Na+ salt) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab56889 (10 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-mouse polyclonal antibody (ab96879) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- Chemical Structure
Lab
Chemical Structure - Nigericin Na+ salt, K+ ionophore (AB120494)
2D chemical structure image of ab120494, Nigericin Na+ salt, K+ ionophore
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal of cardiothoracic surgery 19:208 PubMed38616256
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of cell biology 222: PubMed37010469
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 6: PubMed33350984
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 31:107659 PubMed32433968
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com